Mereo Biopharma Group PLC
NASDAQ:MREO

Watchlist Manager
Mereo Biopharma Group PLC Logo
Mereo Biopharma Group PLC
NASDAQ:MREO
Watchlist
Price: 3.2 USD -2.14% Market Closed
Updated: May 19, 2024

Mereo Biopharma Group PLC
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Mereo Biopharma Group PLC
PP&E Net Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
Mereo Biopharma Group PLC
NASDAQ:MREO
PP&E Net
£1.8m
CAGR 3-Years
-46%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
PP&E Net
$13m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
PP&E Net
$95.7m
CAGR 3-Years
2%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
PP&E Net
$24.8m
CAGR 3-Years
58%
CAGR 5-Years
41%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
PP&E Net
£42.7m
CAGR 3-Years
5%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
PP&E Net
£509.5m
CAGR 3-Years
8%
CAGR 5-Years
5%
CAGR 10-Years
7%

See Also

What is Mereo Biopharma Group PLC's PP&E Net?
PP&E Net
1.8m GBP

Based on the financial report for Dec 31, 2022, Mereo Biopharma Group PLC's PP&E Net amounts to 1.8m GBP.

What is Mereo Biopharma Group PLC's PP&E Net growth rate?
PP&E Net CAGR 3Y
-46%

Over the last year, the PP&E Net growth was -28%. The average annual PP&E Net growth rates for Mereo Biopharma Group PLC have been -46% over the past three years .